Journal of Clinical Pharmacy and Therapeutics · 2014 · 14 citations · 8 references
Venlafaxine concentrations decreases during pregnancy, and the ratio of the concentrations of O-desmethylvenlafaxine/venlafaxine increases during pregnancy. Pregnant women using venlafaxine are at risk for subtherapeutic concentrations, therefore routine monitoring of concentrations venlafaxine and O-desmethylvenlafaxine is recommendable during pregnancy.
8
The Epidemiology of Major Depressive Disorder
Ronald C. Kessler, Patricia A. Berglund, Olga Demler et al. · JAMA · 2003 · 7.9K citations
Margareta Reis, Trond Oskar Aamo, Olav Spigset et al. · Therapeutic Drug Monitoring · 2009 · 143 citations
Naturalistic Setting, Psychotropic Medication, Psychopharmacology +21